Universal Health (NYSE: UHS) director exercises options, 1,809 shares withheld

Rhea-AI Filing Summary

UNIVERSAL HEALTH SERVICES INC director Singer Maria Ruderman exercised options to acquire 2,500 shares of Class B Common Stock at an exercise price of $138.80 per share. These options had vested in stages between March 17, 2022 and March 17, 2025.

Of the acquired shares, 1,809 were surrendered at a price of $191.8750 per share to cover tax obligations in a code F transaction. After these transactions, she directly owns 8,575 shares of Class B Common Stock, and this specific option grant has been fully exercised.

Insider Trade Summary

2,500 shares exercised/converted

Mixed 3 txns

Insider Singer Maria Ruderman

Role Director

Type	Security	Shares	Price	Value
Exercise	Option To Purchase Class B Common Stock	2,500	$0.00	--
Exercise	Class B Common Stock	2,500	$138.80	$347K
Tax Withholding	Class B Common Stock	1,809	$191.875	$347K

Holdings After Transaction: Option To Purchase Class B Common Stock — 0 shares (Direct); Class B Common Stock — 10,384 shares (Direct)

Footnotes (1)

1. [object Object]

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Singer Maria Ruderman

(Last) (First) (Middle)

245 PARK AVENUE

(Street)

NEW YORK NY 10167

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
UNIVERSAL HEALTH SERVICES INC [ UHS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
03/12/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class B Common Stock	03/12/2026		M		2,500	A	$138.8	10,384	D
Class B Common Stock	03/12/2026		F		1,809	D	$191.875	8,575	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Option To Purchase Class B Common Stock	$138.8	03/12/2026		M			2,500	(1)	03/16/2026	Class B Common Stock	2,500	$0	0	D

Explanation of Responses:

1. Option vested ratably on each of 3/17/2022, 3/17/2023, 3/17/2024 and 3/17/2025.

	/s/ Maria Ruderman Singer	03/13/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did UHS director Singer Maria Ruderman report on this Form 4?

UHS director Singer Maria Ruderman exercised stock options to acquire 2,500 shares of Class B Common Stock at $138.80 per share. This was followed by a tax-related share disposition, all recorded on March 12, 2026 as part of routine equity compensation activity.

How many Universal Health Services (UHS) shares were used for tax withholding?

In connection with the option exercise, 1,809 shares of UHS Class B Common Stock were disposed of in a code F transaction at $191.8750 per share. This represents shares delivered to satisfy tax obligations rather than an open-market sale.

What is Singer Maria Ruderman’s direct UHS share ownership after these Form 4 transactions?

After the reported transactions, Singer Maria Ruderman directly owns 8,575 shares of UHS Class B Common Stock. This figure reflects the 2,500 shares acquired through option exercise, net of the 1,809 shares surrendered to cover tax liabilities on March 12, 2026.

What type of derivative security did the UHS director exercise on this Form 4?

She exercised an option to purchase Class B Common Stock covering 2,500 underlying shares at an exercise price of $138.80 per share. The option vested ratably on March 17 of 2022, 2023, 2024, and 2025 before this exercise.

Does this UHS Form 4 show any open-market buying or selling by the director?

The filing shows an option exercise (code M) and a tax-withholding disposition (code F) at $191.8750 per share. Code F indicates shares delivered to pay tax liabilities, which is different from a discretionary open-market purchase or sale of stock.